Overexpression of glucose-6-phosphate dehydrogenase (G6PD) in GC is associated with oxidative stress adaptation and tumor aggressiveness, positioning it as a candidate prognostic biomarker (Zhang C. et al., 2014). This evidence concerns the gene G6PD and gastric cancer.